Patents by Inventor Kevin Charles Beaumont

Kevin Charles Beaumont has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-GDF15 antibodies, compositions and methods of use
    Patent number: 11566066
    Abstract: The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to GDF15, as well as methods and uses for the antibodies.
    Type: Grant
    Filed: August 15, 2019
    Date of Patent: January 31, 2023
    Assignee: Pfizer Inc.
    Inventors: Kevin Charles Beaumont, Danna M. Breen, Matthew Allister Lambert, Jeffrey Raymond Chabot, Tao He, Ksenya Shchors, James R. Apgar
  • ANTI-GDF15 ANTIBODIES, COMPOSITIONS AND METHODS OF USE
    Publication number: 20220380448
    Abstract: The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to GDF15, as well as methods and uses for the antibodies.
    Type: Application
    Filed: August 1, 2022
    Publication date: December 1, 2022
    Inventors: Kevin Charles Beaumont, Danna M. Breen, Matthew Allister Lambert, Jeffrey Raymond Chabot, Tao He, Ksenya Shchors, James R. Apgar
  • ANTI-GDF15 ANTIBODIES, COMPOSITIONS AND METHODS OF USE
    Publication number: 20200055930
    Abstract: The invention provides antibodies, and antigen-binding fragments thereof, that specifically bind to GDF15, as well as methods and uses for the antibodies.
    Type: Application
    Filed: August 15, 2019
    Publication date: February 20, 2020
    Inventors: Kevin Charles Beaumont, Danna M. Breen, Matthew Allister Lambert, Jeffrey Raymond Chabot, Tao He, Ksenya Shchors, James R. Apgar